Harvard Bioscience, Inc. is a developer, manufacturer and seller of technologies, products and services that enable fundamental advances in life science applications, including research, pharmaceutical and therapy discovery, bioproduction and preclinical testing for pharmaceutical and therapy development. Its products and services are sold globally to customers ranging from renowned academic institutions and government laboratories to pharmaceutical, biotechnology and contract research organizations (CROs). Its two product categories are cellular and molecular technology (CMT) and Preclinical. The CMT product family is primarily composed of products supporting research related to molecular, cellular, organ and organoid technologies. The Preclinical product family includes products that support the preclinical research and testing phase for drug development, and in particular, testing related to data collection and analysis for safety and regulatory compliance.
종목 코드 HBIO
회사 이름Harvard Bioscience Inc
상장일Oct 21, 2013
CEOMr. John D. Duke
직원 수330
유형Ordinary Share
회계 연도 종료Oct 21
주소84 October Hill Rd
도시HOLLISTON
증권 거래소NASDAQ Global Market Consolidated
국가United States of America
우편 번호01746-1371
전화15088938999
웹사이트https://www.harvardbioscience.com/
종목 코드 HBIO
상장일Oct 21, 2013
CEOMr. John D. Duke
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.

데이터 없음